Application of 1,3,4-3-O-gallnut acyl-6-O-coffee acyl-beta-D-glucopyranose in preparing antineoplastic medicament

A technology based on glucopyranose and galloyl, which is applied in the field of medicine and can solve the problems of unseen pharmacological activity, usage and drug reports.

Inactive Publication Date: 2008-04-02
SOUTHERN MEDICAL UNIVERSITY
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

No reports on the pharmacological activity, usage and medicam

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 1,3,4-3-O-gallnut acyl-6-O-coffee acyl-beta-D-glucopyranose in preparing antineoplastic medicament

Examples

Experimental program
Comparison scheme
Effect test

example 2

[0159] 【prescription】

[0160] 1,3,4-Tri-O-galloyl-6-O-caffeoyl-β-D-glucopyranose 10g

[0161] Microcrystalline Cellulose 48g

[0162] Soluble starch 40g

[0163] Talc powder 2g

[0164] A total of 1000 tablets were produced, each containing 100 mg of the compound.

[0165] 【Preparation】

[0166] Weigh 10g of the compound, add soluble starch to dilute to 50g, mix well, then weigh 48g of microcrystalline cellulose, use 95% ethanol to make soft material, sieve and granulate, dry at low temperature at 50°C, granulate, add talc powder 2g , mixed evenly, compressed into tablets (0.1g each), inspected for quality, packaged, and obtained.

[0167] 【Dosage】

[0168] 2-3 tablets each time, 3 times a day.

[0169] 【For people】

[0170] Applicable to various tumor patients.

example 3

[0172] 【prescription】

[0173] 1,3,4-Tri-O-galloyl-6-O-caffeoyl-β-D-glucopyranose 5g

[0174]Microcrystalline Cellulose 48g

[0175] Soluble starch 45g

[0176] Talc powder 2g

[0177] A total of 1000 tablets were produced, each containing 100 mg of the compound.

[0178] 【Preparation】

[0179] Weigh 5g of the compound, add soluble starch to dilute to 50g, mix well, then weigh 48g of microcrystalline cellulose, use 95% ethanol to make soft material, sieve and granulate, dry at low temperature at 50°C, granulate, add talc powder 2g , mixed evenly, compressed into tablets (0.1g each), inspected for quality, packaged, and obtained.

[0180] 【Dosage】

[0181] 2-3 tablets each time, 3 times a day.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides an application method of 1, 3, 4-3-tri-O-galloyl acyl -6-O- caffeoyl-Beta-D- glucopyranose in preparing tumor antitumor drugs, in particular the application of glucoseglucopyranose in preparing inducing agent to inhibit the growth of tumor cells and to accelerate tumor cell apoptosis. The invention also provides a tumor antitumor drug, which contains 5 to 20 percent of 1, 3, 4-3-tri-O-galloyl acyl -6-O- caffeoyl-Beta-D- glucopyranose.

Description

technical field [0001] The invention relates to the field of medicine, in particular to the new application of 1,3,4-tri-O-galloyl-6-O-caffeoyl-β-D-glucopyranose. Background technique [0002] 1,3,4-Tri-O-galloyl-6-O-caffeoyl-β-D-glucopyranose is a methanolic extract from the aerial part of the plant Balanophora japonica Makino in the family Balanophoraceae A compound isolated from , its chemical formula is as shown in formula I. The compound is a yellow non-crystalline powder that can be hydrolyzed by tannase into gallic acid and 6-O-caffeoyl-β-D-glucopyranose (Caffeoyl, Coumaroyl, Galloyl, and Hexahydroxydiphenoyl Glucoses from Balanophora japonica. Zhi-Hong JIANG, Yoko HIROSE, et. Chem. Pharm. Bull. 49(7) 887-892 (2001) Chem.). There is no report on the pharmacological activity, use and medicament of the compound after searching the literature. [0003] Contents of the invention [0004] The purpose of the present invention is to provide a new application of 1,3,4...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7032A61P35/00
Inventor 吴少瑜文晓芸姜志宏刘中秋张嘉杰饶进军王广发徐伟吕琳吴曙光
Owner SOUTHERN MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap